Needs of Maori a priority to address poor stomach cancer survival - researchers

August 21, 2014

New research shows that Māori diagnosed with stomach cancer are 27% less likely to survive than non-Māori, prompting calls for recently-released national stomach cancer standards to prioritise the needs of Māori.

A just-published University of Otago, Wellington study comparing 172 Māori stomach cancer patients with 163 non-Māori patients found Māori patients were younger, more likely to have disease in the lower (distal) part of the stomach, had less access to specialised surgical services, and were less likely to survive once diagnosed.

Lead researcher Virginia Signal says Māori have five times the rate of stomach cancer compared with non-Māori, and the study's finding about their survival is consistent with previous research.

On average around 390 people in New Zealand develop stomach cancer each year and 276 die of the disease.

The differences in the type of care that Māori stomach cancer patients receive may, at least in part, account for their poorer survival, Signal says.

"Because Māori are more likely to have distal disease, they are more likely to undergo less complex partial gastrectomy. However, they are less likely to have surgery performed by a specialist upper gastrointestinal surgeon and less likely to be treated in a main centre, regardless of where their tumour is sited," she says.

The higher rate of distal cancer for Māori also suggests differing factors causing the disease than those for non-Māori, Ms Signal says.

Infection with H Pylori – the bacterium that causes chronic inflammation of the inner lining of the stomach (gastritis) – and smoking are two known risk factors for distal . H Pylori infection tends to be acquired in childhood, and is associated with overcrowding and deprivation, she says.

"Further research into the risk factors for Māori is needed, but these findings add weight to a continued emphasis on childhood poverty and reducing smoking among Māori, as well as investigating other for, and treatment of, H Pylori infection, particularly among Māori."

A further concern highlighted by the study is the higher likelihood of comorbidities among Māori patients, Signal says.

The presence of one or more additional diseases is known to impact on patients' quality of care and survival rate, she says.

"Comorbidity amplifies the complexity of, and can delay or change, the treatment pathway. These patients require well-coordinated care and services to ensure they have the best possible patient journey."

While the recent publication of national standards for the provision of services for upper gastrointestinal in New Zealand and the introduction of faster times and care coordination are positive developments, Māori must be prioritised in order to address inequities, Signal says.

"The next step for our research will be to talk to key people in the cancer sector about these findings and how to ensure that prioritisation occurs."

The study is published online in the international peer-reviewed journal Gastric Cancer.

Explore further: New research shows early Maori probably suffered from gout

Related Stories

New research shows early Maori probably suffered from gout

October 30, 2013
(Medical Xpress)—Discoveries of early Māori skeletal remains showing tell-tale signs of gout have been corroborated by new evidence that dispels the myth that the disease was largely an upper class European affliction ...

Pregnant Maori teens let down by system despite positive health-seeking behaviour

May 2, 2014
A new study dispels the myth that young pregnant Māori women delay access to antenatal care in their first trimester.

Thyroid cancer risk in New Zealand highest among Pacific women

June 6, 2014
Just-published research shows Pacific women have the highest rates of thyroid cancer in New Zealand.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.